Q4 2024 |
515 |
$1.25B |
+$398M |
-$38.4M |
+$359M |
ACIO, DRSK, JUCY, SCHX, OSCV
|
13F-HR |
2/14/2025, 09:00 AM |
Q3 2024 |
449 |
$924M |
+$48.2M |
-$14.7M |
+$33.4M |
ACIO, DRSK, JUCY, SCHX, OSCV
|
13F-HR |
11/14/2024, 09:00 AM |
Q2 2024 |
438 |
$855M |
+$64.5M |
-$28.1M |
+$36.3M |
ACIO, DRSK, JUCY, SCHX, OSCV
|
13F-HR |
8/14/2024, 09:00 AM |
Q1 2024 |
449 |
$817M |
+$126M |
-$14.4M |
+$111M |
ACIO, DRSK, JUCY, OSCV, SCHX
|
13F-HR |
5/15/2024, 09:00 AM |
Q4 2023 |
438 |
$658M |
+$52.7M |
-$36.9M |
+$15.9M |
ACIO, DRSK, OSCV, SCHX, XHLF
|
13F-HR |
2/14/2024, 09:00 AM |
Q3 2023 |
441 |
$588M |
+$110M |
-$86.4M |
+$23.5M |
ACIO, DRSK, OSCV, SCHX, JEPI
|
13F-HR |
11/14/2023, 09:00 AM |
Q2 2023 |
442 |
$584M |
+$45.2M |
-$52.6M |
-$7.42M |
ACIO, DRSK, OSCV, JEPI, RDVY
|
13F-HR |
8/14/2023, 10:00 AM |
Q1 2023 |
410 |
$570M |
+$49M |
-$13.9M |
+$35.1M |
DRSK, ACIO, OSCV, ADME, JEPI
|
13F-HR |
5/15/2023, 09:00 AM |
Q4 2022 |
374 |
$520M |
+$37.5M |
-$74M |
-$36.5M |
DRSK, ACIO, OSCV, ADME, FTCS
|
13F-HR |
2/14/2023, 08:00 AM |
Q3 2022 |
331 |
$536M |
+$28.7M |
-$9.44M |
+$19.3M |
DRSK, ACIO, ADME, OSCV, FTCS
|
13F-HR |
11/14/2022, 08:00 AM |
Q2 2022 |
340 |
$547M |
+$366M |
-$10.5M |
+$356M |
DRSK, ACIO, ADME, OSCV, FTCS
|
13F-HR |
8/15/2022, 07:19 AM |
Q1 2022 |
241 |
$231M |
+$47M |
-$20.8M |
+$26.3M |
DRSK, ACIO, ADME, OSCV, VOO
|
13F-HR |
5/16/2022, 09:53 AM |
Q4 2021 |
234 |
$232M |
|
|
|
DRSK, ADME, ACIO, VOO, MSFT
|
Restatement |
5/16/2022, 09:26 AM |